bioAffinity Technologies, Inc.今日正式宣告,其先前披露的1比15反向股票拆分计划,已确定于2026年8月24日美股开盘之际正式落地。此举意味着,每15股现有普通股将自动合并为1股新股,公司总股本相应大幅缩减,而每股股价则按比例抬升。
bioAffinity Technologies, Inc.今日正式宣告,其先前披露的1比15反向股票拆分计划,已确定于2026年8月24日美股开盘之际正式落地。此举意味着,每15股现有普通股将自动合并为1股新股,公司总股本相应大幅缩减,而每股股价则按比例抬升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.